LBA40_PR ARIEL3: a phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC).
dc.contributor.author | Ledermann, J | |
dc.contributor.author | Oza, A | |
dc.contributor.author | Lorusso, D | |
dc.contributor.author | Aghajanian, C | |
dc.contributor.author | Oaknin, A | |
dc.contributor.author | Dean, A | |
dc.contributor.author | Colombo, N | |
dc.contributor.author | Weberpals, J | |
dc.contributor.author | Clamp, Andrew R | |
dc.contributor.author | Scambia, G | |
dc.contributor.author | Leary, A | |
dc.contributor.author | Holloway, R | |
dc.contributor.author | O'Malley, D | |
dc.contributor.author | Cameron, T | |
dc.contributor.author | Maloney, L | |
dc.contributor.author | Goble, S | |
dc.contributor.author | Lin, K | |
dc.contributor.author | Sun, J | |
dc.contributor.author | Giordano, H | |
dc.contributor.author | Coleman, R | |
dc.date.accessioned | 2017-11-23T21:40:56Z | |
dc.date.available | 2017-11-23T21:40:56Z | |
dc.date.issued | 2017-09 | |
dc.identifier.citation | LBA40_PR ARIEL3: a phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC). 2017, 28(suppl_5): Ann Oncol | en |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.doi | 10.1093/annonc/mdx440.034 | |
dc.identifier.uri | http://hdl.handle.net/10541/620700 | |
dc.language.iso | en | en |
dc.relation.url | http://academic.oup.com/annonc/article/doi/10.1093/annonc/mdx440.034/4109946/LBA40PRARIEL3-A-phase-3-randomised-doubleblind | en |
dc.rights | Archived with thanks to Annals of Oncology | en |
dc.title | LBA40_PR ARIEL3: a phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC). | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Gynaecological Oncology, University College London Cancer Institute and UCL Hospitals, London | en |
dc.identifier.journal | Annals of Oncology | en |